$2.12 Billion is the total value of BRADLEY FOSTER & SARGENT INC/CT's 349 reported holdings in Q4 2014. The portfolio turnover from Q3 2014 to Q4 2014 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| WBA | New | Walgreens Boots Alliance Inc | $22,267,000 | – | 292,215 | +100.0% | 1.05% | – |
| VDE | New | Vanguard Energy ETF | $1,982,000 | – | 17,756 | +100.0% | 0.09% | – |
| CDK | New | CDK Global Inc | $1,890,000 | – | 46,370 | +100.0% | 0.09% | – |
| CRC | New | California Resources Corporati | $744,000 | – | 134,958 | +100.0% | 0.04% | – |
| HYH | New | Halyard Health Inc | $573,000 | – | 12,594 | +100.0% | 0.03% | – |
| OMCL | New | OmniCell Inc | $503,000 | – | 15,195 | +100.0% | 0.02% | – |
| SWN | New | Southwestern Energy | $268,000 | – | 9,805 | +100.0% | 0.01% | – |
| BLUE | New | bluebird bio Inc | $283,000 | – | 3,090 | +100.0% | 0.01% | – |
| FE | New | First Energy Corp | $263,000 | – | 6,742 | +100.0% | 0.01% | – |
| XEL | New | XCEL Energy | $232,000 | – | 6,450 | +100.0% | 0.01% | – |
| EQR | New | Equity Residential | $230,000 | – | 3,200 | +100.0% | 0.01% | – |
| ALNY | New | Alnylam Pharmaceuticals | $242,000 | – | 2,500 | +100.0% | 0.01% | – |
| BLK | New | BlackRock Inc | $206,000 | – | 577 | +100.0% | 0.01% | – |
| HCN | New | Health Care REIT Inc. | $202,000 | – | 2,670 | +100.0% | 0.01% | – |
| XLP | New | Sector SPDR TR Con Stpls of Be | $209,000 | – | 4,310 | +100.0% | 0.01% | – |
| GPC | New | Genuine Parts | $212,000 | – | 1,985 | +100.0% | 0.01% | – |
| FMI | New | Foundation Medicine Inc | $220,000 | – | 9,895 | +100.0% | 0.01% | – |
| GLW | New | Corning | $207,000 | – | 9,011 | +100.0% | 0.01% | – |
| EMC | New | EMC | $223,000 | – | 7,497 | +100.0% | 0.01% | – |
| RTN | New | Raytheon | $212,000 | – | 1,963 | +100.0% | 0.01% | – |
| TROW | New | Price T Rowe Group Inc | $215,000 | – | 2,500 | +100.0% | 0.01% | – |
| XLI | New | Sector SPDR Indl Select of Ben | $200,000 | – | 3,535 | +100.0% | 0.01% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-02-09
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Microsoft | 44 | Q2 2024 | 6.1% |
| Apple Inc | 44 | Q2 2024 | 5.0% |
| J P Morgan Chase | 44 | Q2 2024 | 3.8% |
| Danaher | 44 | Q2 2024 | 3.7% |
| Pepsico | 44 | Q2 2024 | 2.4% |
| Johnson & Johnson | 44 | Q2 2024 | 2.3% |
| Thermo Fisher Scientific | 44 | Q2 2024 | 2.8% |
| Marsh & McLennan | 44 | Q2 2024 | 2.0% |
| Walt Disney | 44 | Q2 2024 | 2.5% |
| Amazon.Com | 44 | Q2 2024 | 2.6% |
View BRADLEY FOSTER & SARGENT INC/CT's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| METROLOGIC INSTRUMENTS INC | February 11, 2000 | 293,562 | 5.4% |
View BRADLEY FOSTER & SARGENT INC/CT's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-08-09 |
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-08 |
| 13F-HR | 2023-05-08 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-11 |
| 13F-HR | 2022-05-16 |
View BRADLEY FOSTER & SARGENT INC/CT's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.